Page last updated: 2024-08-24

2,4-diaminoquinazoline and trimethoprim

2,4-diaminoquinazoline has been researched along with trimethoprim in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowden, K; Harris, NV; Smith, C1
Crippen, GM; Ghose, AK1
Battershell, C; Hopfinger, AJ; Malhotra, D1
Baccanari, DP; Boytos, CM; Chan, JH; Hong, JS; Joyner, SS; Kuyper, LF; Rudolph, SK; Tansik, RL1

Other Studies

4 other study(ies) available for 2,4-diaminoquinazoline and trimethoprim

ArticleYear
Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Cattle; Chemical Phenomena; Chemistry; Escherichia coli; Escherichia coli Infections; Folic Acid Antagonists; Liver; Mice; Molecular Structure; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship

1990
Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
    Journal of medicinal chemistry, 1983, Volume: 26, Issue:7

    Topics: Chemical Phenomena; Chemistry; Folic Acid Antagonists; Molecular Conformation; Quinazolines; Streptococcus; Structure-Activity Relationship; Triazines

1983
Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
    Journal of medicinal chemistry, 1981, Volume: 24, Issue:7

    Topics: Chemical Phenomena; Chemistry, Physical; Folic Acid Antagonists; Models, Molecular; Molecular Conformation; Quinazolines; Structure-Activity Relationship

1981
Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.
    Journal of medicinal chemistry, 1995, Sep-01, Volume: 38, Issue:18

    Topics: Animals; Antifungal Agents; Candida albicans; Drug Design; Folic Acid Antagonists; Humans; Mice; Pyrimethamine; Pyrimidines; Quinazolines; Recombinant Proteins; Structure-Activity Relationship; Trimethoprim; Trimetrexate

1995